Robert Bazemore Jr.

All filings by Robert Bazemore Jr. on record concern Eupraxia Pharmaceuticals Inc. We count 5 filings; the first trade dates from 18 June 2026 and the latest from 25 June 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 30 June 2026: a transaction, in Eupraxia Pharmaceuticals Inc. Typically, a trade is published a median of 12 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.